134 related articles for article (PubMed ID: 36257875)
1. Evaluation of human adipose-derived mesenchymal stromal cell Toll-like receptor priming and effects on interaction with prostate cancer cells.
Rivera-Cruz CM; Figueiredo ML
Cytotherapy; 2023 Jan; 25(1):33-45. PubMed ID: 36257875
[TBL] [Abstract][Full Text] [Related]
2. Toll like receptor 3 & 4 responses of human turbinate derived mesenchymal stem cells: stimulation by double stranded RNA and lipopolysaccharide.
Hwang SH; Cho HK; Park SH; Lee W; Lee HJ; Lee DC; Oh JH; Park SH; Kim TG; Sohn HJ; Kang JM; Kim SW
PLoS One; 2014; 9(7):e101558. PubMed ID: 25004159
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stromal Cells Primed by Toll-like Receptors 3 and 4 Enhanced Anti-Inflammatory Effects against LPS-Induced Macrophages via Extracellular Vesicles.
Hwang S; Sung DK; Kim YE; Yang M; Ahn SY; Sung SI; Chang YS
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003458
[TBL] [Abstract][Full Text] [Related]
4. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.
Waterman RS; Tomchuck SL; Henkle SL; Betancourt AM
PLoS One; 2010 Apr; 5(4):e10088. PubMed ID: 20436665
[TBL] [Abstract][Full Text] [Related]
5. Differential MSC activation leads to distinct mononuclear leukocyte binding mechanisms.
Kota DJ; DiCarlo B; Hetz RA; Smith P; Cox CS; Olson SD
Sci Rep; 2014 Apr; 4():4565. PubMed ID: 24691433
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils.
Cassatella MA; Mosna F; Micheletti A; Lisi V; Tamassia N; Cont C; Calzetti F; Pelletier M; Pizzolo G; Krampera M
Stem Cells; 2011 Jun; 29(6):1001-11. PubMed ID: 21563279
[TBL] [Abstract][Full Text] [Related]
7. TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell-Mediated Treg Induction via Notch Signaling.
Rashedi I; Gómez-Aristizábal A; Wang XH; Viswanathan S; Keating A
Stem Cells; 2017 Jan; 35(1):265-275. PubMed ID: 27571579
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.
Liotta F; Angeli R; Cosmi L; Filì L; Manuelli C; Frosali F; Mazzinghi B; Maggi L; Pasini A; Lisi V; Santarlasci V; Consoloni L; Angelotti ML; Romagnani P; Parronchi P; Krampera M; Maggi E; Romagnani S; Annunziato F
Stem Cells; 2008 Jan; 26(1):279-89. PubMed ID: 17962701
[TBL] [Abstract][Full Text] [Related]
9. The role of Toll-like receptor 3 and 4 in regulating the function of mesenchymal stem cells isolated from umbilical cord.
Zhang L; Liu D; Pu D; Wang Y; Li L; He Y; Li Y; Li L; Qiu Z; Zhao S; Li W
Int J Mol Med; 2015 Apr; 35(4):1003-10. PubMed ID: 25695694
[TBL] [Abstract][Full Text] [Related]
10. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
[TBL] [Abstract][Full Text] [Related]
11. Characterization of mesenchymal stem cells under the stimulation of Toll-like receptor agonists.
Chen X; Zhang ZY; Zhou H; Zhou GW
Dev Growth Differ; 2014 Apr; 56(3):233-44. PubMed ID: 24645700
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.
Raicevic G; Najar M; Pieters K; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2012 Jul; 18(13-14):1410-8. PubMed ID: 22429150
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium-induced colitis model.
Fuenzalida P; Kurte M; Fernández-O'ryan C; Ibañez C; Gauthier-Abeliuk M; Vega-Letter AM; Gonzalez P; Irarrázabal C; Quezada N; Figueroa F; Carrión F
Cytotherapy; 2016 May; 18(5):630-41. PubMed ID: 27059200
[TBL] [Abstract][Full Text] [Related]
14. Human adipose-derived mesenchymal stromal cell pigment epithelium-derived factor cytotherapy modifies genetic and epigenetic profiles of prostate cancer cells.
Zolochevska O; Shearer J; Ellis J; Fokina V; Shah F; Gimble JM; Figueiredo ML
Cytotherapy; 2014 Mar; 16(3):346-56. PubMed ID: 24424267
[TBL] [Abstract][Full Text] [Related]
15. A Study of the Immunoregulatory Function of TLR3 and TLR4 on Mesenchymal Stem Cells in Ankylosing Spondylitis.
Li Y; Huang L; Cai Z; Deng W; Wang P; Su H; Wu Y; Shen H
Stem Cells Dev; 2019 Oct; 28(20):1398-1412. PubMed ID: 31456484
[TBL] [Abstract][Full Text] [Related]
16. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells.
Strioga M; Viswanathan S; Darinskas A; Slaby O; Michalek J
Stem Cells Dev; 2012 Sep; 21(14):2724-52. PubMed ID: 22468918
[TBL] [Abstract][Full Text] [Related]
17. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype.
Romieu-Mourez R; François M; Boivin MN; Bouchentouf M; Spaner DE; Galipeau J
J Immunol; 2009 Jun; 182(12):7963-73. PubMed ID: 19494321
[TBL] [Abstract][Full Text] [Related]
18. Poly I:C-priming of adipose-derived mesenchymal stromal cells promotes a pro-tumorigenic phenotype in an immunocompetent mouse model of prostate cancer.
Rivera-Cruz CM; Kumar S; Figueiredo ML
Front Cell Dev Biol; 2023; 11():1145421. PubMed ID: 38078010
[No Abstract] [Full Text] [Related]
19. Priming TLR3 and TLR4 in human adipose- and olfactory mucosa-derived mesenchymal stromal cells and comparison of their cytokine secretions.
Jafari M; Asghari A; Delbandi AA; Jalessi M; Jazayeri MH; Samarei R; Tajik N
Cytotechnology; 2020 Feb; 72(1):57-68. PubMed ID: 31898754
[TBL] [Abstract][Full Text] [Related]
20. Tonsil-derived mesenchymal stromal cells produce CXCR2-binding chemokines and acquire follicular dendritic cell-like phenotypes under TLR3 stimulation.
Ryu JH; Park M; Kim BK; Ryu KH; Woo SY
Cytokine; 2015 Jun; 73(2):225-35. PubMed ID: 25794662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
